Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy.

Slides:



Advertisements
Similar presentations
TC 1600 Biotechnology and Pharmaceutical Customer Partnership Meeting John Doll - Commissioner for Patents November 10, 2005.
Advertisements

Speeding It Up at the USPTO
Daphne C. Lainson Smart & Biggar/Fetherstonhaugh Overview of USPTO Patent Statistics.
First Action Interview Pilot Program Overview. Pilot Program Objectives Promote personal interviews prior to issuance of a first Office action on the.
School of Health Science AND Human Services Health Science Cluster Biotechnology Research and Development Diagnostic Services CAS — Public Health and Advanced.
Accelerating Patent Prosecution Thursday, October 18, 2012.
1 1 1 AIPLA American Intellectual Property Law Association USPTO Updates Including Glossary Pilot Program Chris Fildes Fildes & Outland, P.C. IP Practice.
PROSECUTION APPEALS Presented at: Webb & Co. Rehovot, Israel Date: February 14, 2013 Presented by: Roy D. Gross Associate St. Onge Steward Johnston & Reens.
Appeal Practice Before Board of Patent Appeals and Interferences
1 Clearing the Oldest Patent Applications (COPA) John Barlow Subject Matter Expert Technology Center 2800.
1 Patent Operations: Updates & Highlights Austin Intellectual Property Law Association Austin, TX March 23, 2010.
Q. TODD DICKINSON EXECUTIVE DIRECTOR, AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) USPTO PUBLIC MEETING JULY 20, 2010 AIPLA Comments: Enhanced.
Accelerated Examination Bennett Celsa (TC 1600: QAS)
John J. Calvert Administrator, Inventor Assistance Program John J. Calvert Administrator, Inventor Assistance Program Patents – Past, Present and Future.
M ERCER E NGINEERING M ERCER E NGINEERING Different by Design Dr. Donald Ekong, PE
Proposed Rule Changes to Focus the Patent Process Involving Continuations, Double Patenting and Claims Connecticut Intellectual Property Law Association.
Application Filings and Examiner Production. UPR Applications Filed
The United States Patent and Trademark Office March 15, 2005 BCP Customer Partnership Meeting.
THE STATE OF THE PATENT SYSTEM BACKGROUND FOR RULE PROPOSALS Los Angeles Intellectual Property Law Association “Washington and the West” Conference January.
The United States Patent and Trademark Office July 19, 2005 The National Association of Patent Practitioners 2005 Patent Practice Update.
John Doll – Commissioner for Patents February 1, 2006.
Patent Term Adjustment (Bio/Chem. Partnership) Kery Fries, Sr. Legal Advisor Phone: (571)
Patent Quality Assurance Program. 2 Office of Patent Quality Assurance (OPQA) Deputy Commissioner for Patent Operations Office of Patent Quality Assurance.
You’ve Built a Better Mousetrap...Now what? How to Protect Your Intellectual Property Using Patents and Trademarks Elizabeth Dougherty Acting Deputy Director.
General Information on Patents and the Patent Process presented to North American Association of State and Provincial Lotteries June 24, 2008 Brian Hanlon,
John Doll Commissioner for Patents. 2 USPTO Request for Public Input: Strategic Planning  Agency developing new strategic plan  Part of budget process.
July 18, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818/P.L ) Topic: Patent Fees Office of Patent Legal.
Charles R. Eloshway Patent Attorney Office of International Relations U.S. Patent and Trademark Office Conference on Intellectual Property in the Global.
Ashok K. Mannava Mannava & Kang, P.C. Expedited Examination Programs from the PTO February 12, 2012.
December 8, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818)(upon enactment) and 35 U.S.C. 103(c) as Amended by.
The New USPTO Rules and their Impact on Biomedical Patent Prosecution Mojdeh Bahar, J.D.,M.A. Technology Licensing Specialist Office of Technology Transfer.
2 23,503 hours in FY 2013, compared with 21,273 hours in FY ,651 interview hours in FY 13 have been charged through the AFCP program. Interview.
A View from Both Worlds: USPTO and the Federal Labs Mojdeh Bahar, J.D.,M.A. Technology Licensing Specialist Office of Technology Transfer National Institutes.
1 PPAC Patents Operations Update June 18th, 2009.
1 1 Interview Practice Within the USPTO. 2 2 Topics Effective Interviews Reaching Agreement Requesting Interviews Issues Discussed Documenting Interviews.
Customer Partnership Meeting John Doll Commissioner for Patents.
Developing A Comprehensive Database For Assessing The Patenting Activity In India Sujit Bhattacharya National Institute of Science Technology and Development.
Our Divided Patent System John R. Allison University of Texas McCombs School of Business Mark A. Lemley Stanford Law School David L. Schwartz Northwestern.
1 Biotechnology/Chemical/Pharmaceutical Customer Partnership June 1, 2010 Valencia Martin-Wallace – Director, Technology Center 2400.
1 The CREATE Act and Other Interesting IP Tidbits Brian R. Stanton, Ph.D. Director, Division of Policy Office of Technology Transfer National Institutes.
USPTO Patent Quality Composite presented to Biotechnology/Chemical/Pharmaceutical Customer Partnership September 5, 2012 by Martin Rater Statistician USPTO,
BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. Patent.
After Final Practice Linda M. Saltiel June 2, 2015.
Claims and Continuations Final Rule Overview Briefing for Examiners 1.
USPTO Updated Strategic Plan in Brief March 3 rd, 2010.
Leon Radomsky The Marbury Law Group PLLC Interview Practice and Knowing the USPTO.
Patent Prosecution May PCT- RCE Zombie 371 National Stage PCT Applications –Not Allowed to file an RCE until signed inventor oath/declaration is.
QualityDefinition.PPACMeeting AdlerDraft 1 1 Improving the Quality of Patents Marc Adler PPAC meeting June 18, 2009.
FY09 Restriction Petition Update; Comparison of US and National Stage Restriction Practice Julie Burke TC1600 Quality Assurance Specialist
OCFO - Financial Status of USPTO May 7, FY 2010 Status Authorized level of $1,887.0 million Mid-year Budget Execution Review currently underway.
Chris Fildes FILDES & OUTLAND, P.C. IP Practice in Japan Committee Pre-Meeting AIPLA Annual Meeting, October 20, 2015 USPTO PILOT PROGRAMS 1 © AIPLA 2015.
Claims Proposed Rulemaking Main Purposes É Applicant Assistance to Improve Focus of Examination n Narrow scope of initial examination so the examiner is.
FY 2010 and FY 2011 Budget and Fee Collection Update March 3, 2010.
Andrew B. Freistein Wenderoth, Lind & Ponack, L.L.P. Learning the ABC’s of Patent Term Adjustment 1 © AIPLA 2015.
Bruce Kisliuk Group Director, Technology Center 1600.
“Welcome to the Table” May 15, 2006 Jay Lucas Deputy Commissioner for Patent Examination Policy.
First Action Interview Pilot Program Legal Secretaries & Administrators Conference June 18, 2009.
1 PPAC Patents Operations Update Peggy Focarino Deputy Commissioner for Patents July 8, 2010.
The United States Patent and Trademark Office January 27, 2005.
1 FY08 Restriction Petition Update and Burden Julie Burke Quality Assurance Specialist Technology Center 1600.
US Patent Application Drafting Center Presentation ppt Patent Stats That Can Help Your Practice Electronic & Computer Law Committee Manny Schecter.
Patents, Trade Secrets and Unfair Competition
Examination Time and the Production System
Boston Patent Law Association
TC 1600 Biotechnology and Pharmaceutical Customer Partnership Meeting
First Action Interview Pilot Program
Los Angeles Intellectual Property Law Association
The National Association of Patent Practitioners (NAPP)
Boston Patent Law Association Annual Meeting
Presentation transcript:

Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy

Application Filings and and Examiner Production Examiner Production

3 UPR Applications Filed   FY 05 plan 375,080 (5.5% above FY 04)   FY 05 actual 384,228 (8.1% above FY04)   2.6% over plan

4 FY 04 FY 05 Target FY 05 UPR 1 FAOM 2 288,315297,614297,287 UPR Disposals 3 287,188295,456279,345 UPR Production Units 4 287,752296,535288,316 PCT Production Units 5 16,88222,91615,147 Production 1 “ UPR” = Utility, Plant, and Reissue Applications. 2 “ FAOM” = First Action on the Merits – first action count by an examiner after the filing of an application (does not include restrictions or other miscellaneous actions). 3 “ Disposal” = An examiner allowance, abandonment, or disposals following a board decision. 4 “ Production Unit” = First action count plus disposal count divided by 2. 5 “ PCT” = Patent Cooperation Treaty. PCT applications are processed differently and tracked separately from US National stage applications. For FY 05, 15,147 PU’s is 35,389 processed applications.

... vs the Backlog PENDENCY

6 Patent Pendency (as of 1/1/2006) Patent Pendency (as of 1/1/2006) Technology Center Average 1 st Action Pendency (months) 1 Average Total Pendency (months) Biotechnology and Organic Chemistry Chemical and Materials Engineering Computer Architecture Software and Information Security – Communications Semiconductor, Electrical, Optical Systems Transportation, Construction, Electronic Commerce Mechanical Engineering, Manufacturing and Products UPR Total (as of 10/1/2005) “Average 1 st action pendency” is the average age from filing to first action for a newly filed application, completed during October-December “Average total pendency” is the average age from filing to issue or abandonment of a newly filed application, completed during October-December 2005.

7 First Action Pendency by Art Areas High Pendency Art Areas Pendency 1 (months) Low Pendency Art Areas Pendency 1 (months) 1640 – Immunology, Receptor/ Ligands, Cytokines, Recombinant Hormones, and Molecular Biology – Heterocyclic Compounds and Uses – Analytic Chemistry & Wave Energy – Radiation Imagery – Simulation and Modeling, Emulation of Computer Components – Manufacturing Control Systems and Chemical/ Mechanical/Electrical Control – Interactive Video Distribution – Dynamic Information Storage & Retrieval – Control Circuits – Electrical Connectors – Finance & Banking, Accounting – Land Vehicles – Surgery: Cutting, Clamping, Suturing – Tools & Metal Working “Average 1 st action pendency” is the average age from filing to first action for a newly filed application, completed during October-December 2005.

8 Inventory by Art Examples High Inventory Art Areas Months of Inventory* Low Inventory Art Areas Months of Inventory* 1614, 1615, and 1617 – Drugs, Bio-affecting and Body Treatment – Organic Chemistry – Radiation Imagery – Adhesive Bonding and Coating Apparatus – Computer Task Management – Manufacturing Control Systems and Chemical/ Mechanical/Electrical Control – Interactive Video Distribution , 2653 – Information Storage and Retrieval – Control Circuits – Electrical Conductors – Business Methods – Conveying and 3737 – Medical Instruments, Diagnostic Equipment – Thermal and Combustion Technology 8 * The number of months it would take to reach a first action on the merits (e.g., an action addressing patentability issues) on a new application filed in July 2005 at today’s production rate. Today’s production rate means that there are no changes in production due to hiring, attrition, changes to examination processing or examination efficiencies, and that applications are taken up in the order of filing in the given art unit/area. Of course, USPTO is taking aggressive steps to ensure changes that will significantly lower the inventory rates in high-inventory art areas.

Total*Design New Applications 1 9/30/ ,40263,92371,77897,38077,65156,73865,005508,87818,451 New Applications 1 9/30/ ,64472,69776,529115,58594,42570,35483,225586,58024,534 Overall Pending Applications 2 9/30/ ,006105,447102,440138,822137,458101,097108,039809,32327,599 Overall Pending Applications 2 9/30/ ,647120,767117,728167,721159,687117,045130,168932,30038,104 TC Application Inventory 1 “ New Application inventory” is the number of new applications designated or assigned to a technology center awaiting a first action. 2 “ Overall Pending Application inventory” is the total number of applications designated or assigned to a technology center in an active status. Includes new applications; rejected awaiting response; amended; under appeal or interference; suspended; reexams and allowed applications awaiting grant publication. *Total inventory includes applications not assigned to a particular TC, awaiting processing either pre- or post-examination.

Patent Quality (Shared Responsibility)

11 Quality of Products – FY 05 Fiscal Year 2005 FY Desig n FY 05 FY 05 Target Patent In-Process Examination Compliance Rate 1* 82.0%81.7%82.9%88.1%84.7%90.9%84.4%86.6%94.3%86.2%84.0% Patent Allowance Error Rate 2* 5.32%4.88%6.46%3.56%2.25%4.43%4.94%6.43%1.6%4.55%4.0% *Compliance and error rates as measured by OPQA. 1 Compliance is the percent of office actions reviewed and found to be free of any in-process examination deficiency (an error that has significant adverse impact on patent prosecution). 2 Patent allowance error rate is the percent of allowed applications reviewed having at least one claim which is considered unpatentable on a basis for which a court would hold a patent invalid. “Allowance” occurs before a patent is issued, so these errors are caught before any patent is actually granted.

Re-Work

13 Technology Centers Rework* Statistics * Rework first actions are those actions that are in a Continuing (CONs and CIPs), RCE, CPA or 129(a) applications (excludes Divisionals).

Hiring and Retention

15 Hires and Attritions CorpsDesign FY 04 Hires FY 04 Attritions FY 05 BOY Examiner Staff FY 05 Hiring (10/1/05) FY 05 Attrits (10/1/05) FY 05 Hiring Goal New Hires as a Percent of Examiner Staffing in the TC 24%13%40%26%25%22%30%26%

Stats and Stuff

17 Total Continuation Filing Rates *Straight Continuations 37 CFR §1.53 (b)(1) – No Divisionals or CIPs – as of 10/23/05

18 Distribution of Independent Claims at Filing

19 Distribution of Total Claims at Filing

20 Total Claims at Filing and Issue

21 Distribution of the Number of References Cited in Applications

Pendency Projections

HistoricWithout Strategic Plan

HistoricWithout Strategic Plan 1,000 Hires & Low Attrits

HistoricWithout Strategic Plan 1,000 Hires & Low AttritsPlus Claims & Continuation Limits

HistoricWithout Strategic Plan1,000 Hires & Low AttritsPlus Claims & Continuation LimitsPlus Patentability Report

Production You Can’t Hire Your Way Out of This One

29

Markush Practice

31 1.A cell adhesion protein of formula (1), A-(B)-(C)-(D) n -E or a pharmaceutically acceptable derivative thereof, wherein...

Accelerated Examination Would You Like Your Patent In 12 Months ?!?

33 Accelerated Examination Features of the proposed revision: Features of the proposed revision:  Move to the head of the line  Final Disposition within 12 months  Program for expedited Issuance of Patents  e-file application and all follow on papers  Single Invention  Limited Number of Claims  Patentability Report  Possible Interview before 1 st Action  Shortened Statutory Period  Enforcement of special status in the Corps

34 Contact Information Joseph Rolla Deputy Commissioner for Patent Examination Policy Phone: